Eisai
4523.T
#2141
Rank
A$13.08 B
Marketcap
A$46.37
Share price
4.08%
Change (1 day)
5.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): A$3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.26. In 2022 the company made an earnings per share (EPS) of A$2.32 a decrease over its 2021 EPS that were of A$10.31.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$3.2640.43%
2022A$2.32-77.48%
2021A$10.31-41.88%
2020A$17.75-0.94%
2019A$17.9152.59%
2018A$11.74124.17%
2017A$5.24-49.42%
2016A$10.3637.08%
2015A$7.55-11.75%
2014A$8.56-3.23%
2013A$8.85-18.56%
2012A$10.86-15.51%
2011A$12.86-3.75%
2010A$13.36-1.36%
2009A$13.54